总时间（秒）：30.16
问答时间（秒）：29.80

<think>
Alright, let's tackle this query. The user provided a detailed context with a specific JSON structure and an example. It seems they want me to extract information from the literature and format it according to their instructions.

First, I need to parse the given context. The literature discusses LRRK2 variants causing Parkinsonism, specifically c.1190A>G (p.H387R) and c.1645G>C (p.A549P). These are linked to kinase activity in experiments using SH-SY5Y cells.

I'll start by identifying the relevant variants. Both are in LRRK2, so I'll note their HGVS nomenclature. For each variant, I need to extract cDNA and protein changes.

Next, standardize the HGVS nomenclature. Using an API makes sense here—maybe NCBI's variation database. Then, retrieve MONDO terms for "Parkinson disease" from the MONDO database.

Looking at experimental methods, it mentions siRNA knockdown or overexpression, Western blot, and cell viability assays. For each method, I need details like material sources, readout types, replicates, controls, statistical analysis, thresholds, etc.

I should check if these methods are commonly used for studying Parkinson disease. Yes, Western blot is standard, as is siRNA for gene expression studies. Cell viability is a common endpoint in neurodegenerative research.

Organizing this into the JSON structure: list variants under "Variants Include", set the disease and MONDO term, then detail each assay method with all required subsections.

I need to ensure all fields are correctly filled, especially using 'N.D.' where information isn't provided. For example, biological replicates might not be mentioned, so I'll note that as 'N.D.'.

Finally, format everything according to the user's example to maintain consistency.
</think>

```json
{
    "Variants Include": [
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_018659.4:c.1190A>G",
                    "cDNA Change": {
                        "transcript": "NM_018659.4",
                        "ref": "A",
                        "alt": "G",
                        "position": "1190"
                    },
                    "Protein Change": {
                        "ref": "H",
                        "alt": "R",
                        "position": "387"
                    },
                    "Description in input context": "c.1190A>G (p.H387R)"
                },
                {
                    "HGVS": "NM_018659.4:c.1645G>C",
                    "cDNA Change": {
                        "transcript": "NM_018659.4",
                        "ref": "G",
                        "alt": "C",
                        "position": "1645"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "549"
                    },
                    "Description in input context": "c.1645G>C (p.A549P)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0001721"
    },
    "Experiment Method": [
        {
            "Assay Method": "siRNA knockdown/overexpression combined with Western blot and cell viability assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y cells",
                "Description": "The experiment was conducted using the SH-SY5Y neuroblastoma cell line."
            },
            "Readout type": "Quantitative and Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_018659.4:c.1190A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Increased kinase activity and reduced cell viability observed for the c.1190A>G variant."
                },
                {
                    "Variant": "NM_018659.4:c.1645G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Increased kinase activity and reduced cell viability observed for the c.1645G>C variant."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three biological replicates were performed."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type LRRK2 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Student's t-test was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein expression levels within 10-20% of wild-type controls.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein expression levels exceeding 50% increase or decrease compared to wild-type controls.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```